I will miss vla. A very long wait, but they had good clinical trial data so they were always worth holding. I think they were worth more than $1.75 - but so be it.
Thanks and best wishes to all.
I like the look of ftt at the moment. Results due soon, snippets of great looking data, negotiating with partners, no real competition. I also like imu, but they might be raising money atm.